Anu Muona, PhD

Anu Muona is a founder and CEO of Aranda. Anu has over 10 years of experience in preclinical drug development in small molecules for various target indications. Prior founding Aranda she has served as a Head of Cellular and Molecular Biology at Medeia Therapeutics Ltd, the originator of ADA-308 program, her major responsibility being the pharmacological development of the program. She has also been a member of a team exploring the potential of bone marrow stem cell-based therapy for the treatment of Alzheimer’s disease at Medeia. Anu has a strong scientific background in molecular biology and genetics. She received her PhD in molecular biology in the Collagen research unit of University of Oulu, Finland. She has completed extensive postdoctoral training in stem cell research and its applications in neurodegenerative diseases at the University of Eastern Finland, Kuopio.

Mr. Heikki Eronen

Heikki Eronen is a Manager in Company Administration and Finance at Aranda. Previously Heikki served in the same task at Medeia Therapeutics Ltd. Heikki brings over 40 years’ of experience to Aranda having served different small to medium-sized companies at various administrative and managerial roles. Heikki is a strong talent especially in accounting and financial planning.